Ocular Therapeutix, Inc.
(NASDAQ : OCUL)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
ABBVAbbVie, Inc. -0.96%92.131.9%$1145.22m
JNJJohnson & Johnson -0.87%144.440.7%$1085.68m
BMYBristol-Myers Squibb Co. -0.57%60.791.0%$940.95m
PFEPfizer Inc. 0.64%37.500.9%$816.71m
MRKMerck & Co., Inc. -0.22%76.380.7%$776.51m
LLYEli Lilly & Co. -0.69%151.231.1%$447.35m
AZNAstraZeneca Plc -0.11%55.221.2%$249.77m
NVSNovartis AG -0.09%84.910.2%$158.95m
GSKGlaxoSmithKline Plc -0.37%40.880.2%$141.36m
BHCBausch Health Cos., Inc. -2.26%17.770.0%$113.04m
SNYSanofi -0.30%47.300.2%$86.66m
NVONovo Nordisk A/S 0.05%64.850.1%$84.91m
RGENRepligen Corp. -0.57%139.517.1%$72.80m
ARCTArcturus Therapeutics Holdings, Inc. 7.71%58.270.0%$57.13m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 11.80%58.370.0%$43.19m

Company Profile

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.